search
Back to results

Anal Crohn Fistula Surgery (FACC)

Primary Purpose

Crohn Disease, Fistula, Anoperineal Fistula

Status
Unknown status
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
All types of surgery procedures
Simple seton drain removal
Sponsored by
French Society of Coloproctology
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Crohn Disease focused on measuring Crohn Disease, Anoperineal fistula, Anal fistula, Proctology, Drainage, Colorectal Surgery, Fistulotomy, Plug, Advancement flap, Glue, Anti Tumor Necrosis Factor-alpha, Adalimumab

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • male or female 18 years or older,
  • women of childbearing age who use an effective contraception method or women incapable of becoming pregnant [(i.e. postmenopausal women for 1 year or surgically sterile (hysterectomy and/or bilateral oophorectomy)],
  • Patient with fistulizing anoperineal Crohn's disease. Anoperineal fistulas can be associated with ileal, colic or rectal lesions,
  • Patient with at least 1 anoperineal fistula drained with a seton for more than 1 month,
  • Patient treated with adalimumab for more than 1 month,
  • Patient who agrees to undergo surgery for its drained fistula(s),
  • Patient with immunosuppressive therapy (azathioprine, 6-mercaptopurine ou methotrexate) stable for at least 3 months or patients without immunosuppressive therapy,
  • Patient who gave signed written informed consent after having received verbal explanation and written information related to the trial.

Exclusion Criteria:

  • Pregnant or breastfeeding women,
  • Patient having a perineal abscess,
  • Patient with a high anovaginal fistula that cannot be treated, according to the investigator ,with fistulotomy, gluing, biodegradable plug or advancement flap,
  • Patient treated with a daily dose of corticosteroids of more than 20 mg (a dose of more than 20 mg daily will be authorized during the study),
  • Contraindication to proctological surgery on the drained fistula(s),
  • Patient presenting with somatic or psychic signs or symptoms that are not compatible with his/her participation in the trial according to the investigator,
  • Patient who participate in another clinical trial.

Sites / Locations

  • CHU Bordeaux - Hôpital Saint André - Department of Hepato GastroenterologyRecruiting
  • Maison de Santé Protestante de Bordeaux Bagatelle - Department of ProctologyRecruiting
  • CHU Pontchaillou - Department of Digestive Diseases
  • Polyclinique de Franche-Comté - Department of Proctological Surgery
  • CHU de Rouen - Departement of Hepato Gastroenterologie and Nutrition
  • Hôpital Louis Mourier - Department of Hepato-Gastroentérologie
  • Institut de Proctologie Léopold Bellan - Groupe Hospitalier Paris Saint Joseph - Department of Colo-ProctologyRecruiting
  • Institut Mutualiste Montsouris - Proctology Unit
  • Hôpital Bichat-Claude Bernard - Gastro-enterology DepartmentRecruiting
  • Clinique des Cèdres - Hepato-Gastroenterology DepartmentRecruiting
  • Clinique Saint Jean Languedoc - Department of Gastroenterology
  • Clinique universitaire de chirurgie Digestive et de l'urgence, Hopital Universitaire Michallon - Colorectal Surgery UnitRecruiting
  • Hôpital Nord de Marseille - Gastroenterology Department
  • Hôpital de POISSY
  • Polyclinique de l'Océan

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

Surgery

Simple seton drain removal

Arm Description

Seton drain removal is associated with proctological surgery.

Outcomes

Primary Outcome Measures

Percentage of patients having a clinical healing of their anoperineal fistulas in Crohn disease

Secondary Outcome Measures

Proportion of patients having more than half of their fistulas healed
Change in Crohn disease activity assessed by Crohn's Disease Activity Index (CDAI) and Perianal Disease Activity Index (PDAI)
Change in anal continence assessed by Wexner and Vaizey scores
Crohn's Disease Endoscopic Index of Severity (CDEIS)
Change in patients' quality of life, assessed by the Inflammatory Bowel Disease Questionnaire (IBDQ)
Change in fistula activity assessed by magnetic resonance imaging (MRI)
Change in fistula activity assessed by MRI (Van Assche score and absence of contrast enhancement after injection of gadolinium with regards to fistulous tract
Change in discomfort and impact assessed by the patient using a visual analog scale (VAS)

Full Information

First Posted
July 4, 2011
Last Updated
June 6, 2012
Sponsor
French Society of Coloproctology
search

1. Study Identification

Unique Protocol Identification Number
NCT01388257
Brief Title
Anal Crohn Fistula Surgery
Acronym
FACC
Official Title
A National, Multicenter, Randomized Open-Label Study of Proctological Surgery Efficacy on Anoperineal Fistulas Healing in Crohn's Disease Patients Treated With Adalimumab. (Official French Title: "Étude Nationale, Multicentrique, randomisée et en Ouvert de l'efficacité de la Chirurgie Proctologique Sur la Cicatrisation Des Fistules anopérinéales de la Maladie de Crohn Chez Des Patients traités Par Adalimumab")
Study Type
Interventional

2. Study Status

Record Verification Date
June 2012
Overall Recruitment Status
Unknown status
Study Start Date
October 2011 (undefined)
Primary Completion Date
March 2016 (Anticipated)
Study Completion Date
March 2017 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
French Society of Coloproctology

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to demonstrate, in patients treated with adalimumab, the efficacy of proctological surgery in anoperineal fistula healing after the removal of seton drain.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Crohn Disease, Fistula, Anoperineal Fistula, Anal Fistula
Keywords
Crohn Disease, Anoperineal fistula, Anal fistula, Proctology, Drainage, Colorectal Surgery, Fistulotomy, Plug, Advancement flap, Glue, Anti Tumor Necrosis Factor-alpha, Adalimumab

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
180 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Surgery
Arm Type
Experimental
Arm Description
Seton drain removal is associated with proctological surgery.
Arm Title
Simple seton drain removal
Arm Type
Other
Intervention Type
Procedure
Intervention Name(s)
All types of surgery procedures
Intervention Description
All types of surgery procedures used for anoperineal fistula repair. Surgery procedures include fistulotomy, biological glue, rectal advancement flap and plug.
Intervention Type
Procedure
Intervention Name(s)
Simple seton drain removal
Intervention Description
Patients are simply followed after seton drain removal.
Primary Outcome Measure Information:
Title
Percentage of patients having a clinical healing of their anoperineal fistulas in Crohn disease
Time Frame
12 months after seton drain removal
Secondary Outcome Measure Information:
Title
Proportion of patients having more than half of their fistulas healed
Time Frame
3, 6, 12 and 24 months after seton drain removal
Title
Change in Crohn disease activity assessed by Crohn's Disease Activity Index (CDAI) and Perianal Disease Activity Index (PDAI)
Time Frame
3, 6, 12 and 24 months after seton drain removal
Title
Change in anal continence assessed by Wexner and Vaizey scores
Time Frame
12 and 24 months after seton drain removal
Title
Crohn's Disease Endoscopic Index of Severity (CDEIS)
Time Frame
12 months after seton drain removal
Title
Change in patients' quality of life, assessed by the Inflammatory Bowel Disease Questionnaire (IBDQ)
Time Frame
12 and 24 months after seton drain removal
Title
Change in fistula activity assessed by magnetic resonance imaging (MRI)
Description
Change in fistula activity assessed by MRI (Van Assche score and absence of contrast enhancement after injection of gadolinium with regards to fistulous tract
Time Frame
6, 12 and 24 months after seton drain removal
Title
Change in discomfort and impact assessed by the patient using a visual analog scale (VAS)
Time Frame
3, 6, 12 and 24 months after seton drain removal

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: male or female 18 years or older, women of childbearing age who use an effective contraception method or women incapable of becoming pregnant [(i.e. postmenopausal women for 1 year or surgically sterile (hysterectomy and/or bilateral oophorectomy)], Patient with fistulizing anoperineal Crohn's disease. Anoperineal fistulas can be associated with ileal, colic or rectal lesions, Patient with at least 1 anoperineal fistula drained with a seton for more than 1 month, Patient treated with adalimumab for more than 1 month, Patient who agrees to undergo surgery for its drained fistula(s), Patient with immunosuppressive therapy (azathioprine, 6-mercaptopurine ou methotrexate) stable for at least 3 months or patients without immunosuppressive therapy, Patient who gave signed written informed consent after having received verbal explanation and written information related to the trial. Exclusion Criteria: Pregnant or breastfeeding women, Patient having a perineal abscess, Patient with a high anovaginal fistula that cannot be treated, according to the investigator ,with fistulotomy, gluing, biodegradable plug or advancement flap, Patient treated with a daily dose of corticosteroids of more than 20 mg (a dose of more than 20 mg daily will be authorized during the study), Contraindication to proctological surgery on the drained fistula(s), Patient presenting with somatic or psychic signs or symptoms that are not compatible with his/her participation in the trial according to the investigator, Patient who participate in another clinical trial.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Laurent Abramowitz, MD
Phone
140 50 11 22
Ext
+33
Email
laurent.abramowitz@bch.ap-hop-paris.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Laurent Abramowitz, MD
Organizational Affiliation
Hôpital Bichat-Claude Bernard
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU Bordeaux - Hôpital Saint André - Department of Hepato Gastroenterology
City
Bordeaux
State/Province
Aquitaine
ZIP/Postal Code
33075
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Roumeguère-Blond
Email
pauline.roumeguere@chu-bordeaux.fr
First Name & Middle Initial & Last Name & Degree
Pauline Roumeguère-Blond, MD
Facility Name
Maison de Santé Protestante de Bordeaux Bagatelle - Department of Proctology
City
Talence
State/Province
Aquitaine
ZIP/Postal Code
33401
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bouchard
Email
proctobouc@gmail.com
First Name & Middle Initial & Last Name & Degree
Dominique Bouchard, MD
Facility Name
CHU Pontchaillou - Department of Digestive Diseases
City
Rennes
State/Province
Bretagne
ZIP/Postal Code
35033
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Siproudhis
Email
laurent.siproudhis@chu-rennes.fr
First Name & Middle Initial & Last Name & Degree
Laurent Siproudhis, MD, PhD
Facility Name
Polyclinique de Franche-Comté - Department of Proctological Surgery
City
Besançon
State/Province
Franche-Comté
ZIP/Postal Code
25052
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Fantoli
Email
drmichelfantoli@wanadoo.fr
First Name & Middle Initial & Last Name & Degree
Michel Fantoli, MD
Facility Name
CHU de Rouen - Departement of Hepato Gastroenterologie and Nutrition
City
Rouen
State/Province
Haute Normandie
ZIP/Postal Code
76031
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Savoye
Email
guillaume.savoye@chu-rouen.fr
First Name & Middle Initial & Last Name & Degree
Guillaume Savoye, MD
Facility Name
Hôpital Louis Mourier - Department of Hepato-Gastroentérologie
City
Colombes
State/Province
Ile-de-France
ZIP/Postal Code
92700
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Coffin
Email
benoit.coffin@lmr.ap-hop-paris.fr
First Name & Middle Initial & Last Name & Degree
Benoît Coffin, Prof., MD
Facility Name
Institut de Proctologie Léopold Bellan - Groupe Hospitalier Paris Saint Joseph - Department of Colo-Proctology
City
Paris
State/Province
Ile-de-France
ZIP/Postal Code
75014
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sénéjoux
Email
agnes.senejoux@gmail.com
First Name & Middle Initial & Last Name & Degree
Sénéjoux Agnès, MD
Facility Name
Institut Mutualiste Montsouris - Proctology Unit
City
Paris
State/Province
Ile-de-France
ZIP/Postal Code
75014
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Godeberge
Email
philippe.godeberge@wanadoo.fr
First Name & Middle Initial & Last Name & Degree
Philippe Godeberge, MD
Facility Name
Hôpital Bichat-Claude Bernard - Gastro-enterology Department
City
Paris
State/Province
Ile-de-France
ZIP/Postal Code
75877
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Laurent Abramowitz, MD
Phone
1 43 74 61 41
Ext
+33
Email
laurent.abramowitz@bch.ap-hop-paris.fr
First Name & Middle Initial & Last Name & Degree
Laurent Abramowitz, MD
Facility Name
Clinique des Cèdres - Hepato-Gastroenterology Department
City
Cornebarrieu
State/Province
Midi-Pyrénées
ZIP/Postal Code
31700
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bonnaud
Email
hepavie@free.fr
First Name & Middle Initial & Last Name & Degree
Guillaume Bonnaud, MD
Facility Name
Clinique Saint Jean Languedoc - Department of Gastroenterology
City
Toulouse
State/Province
Midi-Pyrénées
ZIP/Postal Code
31077
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Staumont
Email
staumont.ghislain@orange.fr
First Name & Middle Initial & Last Name & Degree
Ghislain Staumont, MD
Facility Name
Clinique universitaire de chirurgie Digestive et de l'urgence, Hopital Universitaire Michallon - Colorectal Surgery Unit
City
Grenoble
State/Province
Rhône-Alpes
ZIP/Postal Code
38043
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Faucheron
Email
jlfaucheron@chu-grenoble.fr
First Name & Middle Initial & Last Name & Degree
Jean-Luc Faucheron, Prof., MD
Facility Name
Hôpital Nord de Marseille - Gastroenterology Department
City
Marseille
ZIP/Postal Code
13915
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jean-Charles GRIMAUD, MD
Email
jean-charles.grimaud@ap-hm.fr
First Name & Middle Initial & Last Name & Degree
Jean-Charles GRIMAUD, MD
Facility Name
Hôpital de POISSY
City
Poissy
ZIP/Postal Code
78303
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Béatrice VINSON-BONNET, MD
Email
bvinson-bonnet@chi-psg.com
First Name & Middle Initial & Last Name & Degree
Béatrice VINSON-BONNET, MD
Facility Name
Polyclinique de l'Océan
City
Saint-Nazaire
ZIP/Postal Code
44600
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Florent JURCZAK, MD
Email
florent.jurczak@mla.fr
First Name & Middle Initial & Last Name & Degree
Florent JURCZAK, MD

12. IPD Sharing Statement

Citations:
PubMed Identifier
34623746
Citation
Abramowitz L, Brochard C, Pigot F, Roumeguere P, Pillant H, Vinson Bonnet B, Faucheron JL, Senejoux A, Bonnaud G, Meurette G, Fayette JM, Train C, Staumont G, Siproudhis L, Bouchard D. Surgical closure, mainly with glue injection and anti-tumour necrosis factor alpha, in fistulizing perianal Crohn's disease: A multicentre randomized controlled trial. Colorectal Dis. 2022 Feb;24(2):210-219. doi: 10.1111/codi.15947. Epub 2021 Oct 23.
Results Reference
derived

Learn more about this trial

Anal Crohn Fistula Surgery

We'll reach out to this number within 24 hrs